trial

dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia

NCTId NCT07658898
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 62 (estimated)
Sponsored by Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Primary completion 2027-12-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
62 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2026-06-30
Primary completion
2027-12-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
temporal interference stimulation

Sponsors

Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji UniversityLead Sponsor

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
62
Phase
NA
Primary Completion Date
2027-12-30
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
temporal interference stimulation
drug
lead_sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
company
indication
Schizophrenia
indication
Schizophrenia Disorder
indication